Adrian Puren to HIV-1
This is a "connection" page, showing publications Adrian Puren has written about HIV-1.
Connection Strength
2,642
-
Evaluation of the accuracy of the Asant? assay as a point-of-care rapid test for HIV-1 recent infections using serum bank specimens from blood donors in South Africa, July 2018 - August 2021. S Afr Med J. 2023 10 23; 113(10):42-48.
Score: 0,488
-
Misdiagnosis of HIV infection during a South African community-based survey: implications for rapid HIV testing. J Int AIDS Soc. 2017 08 29; 20(Suppl 6):21753.
Score: 0,318
-
Comparison of lavage and swabs for the collection of genital ulcer specimens to measure HIV RNA shedding. J Clin Virol. 2009 Oct; 46(2):165-8.
Score: 0,182
-
Investigation of HIV in amniotic fluid from HIV-infected pregnant women at full term. J Infect Dis. 2005 Aug 01; 192(3):488-91.
Score: 0,137
-
The HIV-1 epidemic in South Africa. Oral Dis. 2002; 8 Suppl 2:27-31.
Score: 0,108
-
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults. N Engl J Med. 2021 03 25; 384(12):1089-1100.
Score: 0,102
-
Successes and gaps in the HIV cascade of care of a high HIV prevalence setting in Zimbabwe: a population-based survey. J Int AIDS Soc. 2020 09; 23(9):e25613.
Score: 0,098
-
Rethinking globally relevant vaccine strategies to human immunodeficiency virus type-1. Arch Immunol Ther Exp (Warsz). 2000; 48(4):235-41.
Score: 0,094
-
Assessment of readiness to transition from antenatal HIV surveillance surveys to PMTCT programme data-based HIV surveillance in South Africa: The 2017 Antenatal Sentinel HIV Survey. Int J Infect Dis. 2020 Feb; 91:50-56.
Score: 0,093
-
Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13. BMC Infect Dis. 2019 Sep 16; 19(Suppl 1):787.
Score: 0,092
-
Provincial and national prevalence estimates of transmitted HIV-1 drug resistance in South Africa measured using two WHO-recommended methods. Antivir Ther. 2019; 24(3):203-210.
Score: 0,087
-
Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa. BMC Public Health. 2015 Nov 20; 15:1149.
Score: 0,070
-
Design and implementation of an external quality assessment program for HIV viral load measurements using dried blood spots. J Clin Microbiol. 2015 Mar; 53(3):964-6.
Score: 0,066
-
Evaluation of blood collection filter papers for HIV-1 DNA PCR. J Clin Virol. 2012 Oct; 55(2):101-6.
Score: 0,056
-
Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005-2009. Clin Infect Dis. 2012 May; 54 Suppl 4:S334-8.
Score: 0,055
-
Associations between childhood adversity and depression, substance abuse and HIV and HSV2 incident infections in rural South African youth. Child Abuse Negl. 2010 Nov; 34(11):833-41.
Score: 0,049
-
Determinants of HIV type 1 shedding from genital ulcers among men in South Africa. Clin Infect Dis. 2010 Apr 01; 50(7):1060-7.
Score: 0,048
-
Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial. J Infect Dis. 2009 Oct 01; 200(7):1039-49.
Score: 0,046
-
Poor sensitivity of field rapid HIV testing: implications for mother-to-child transmission programme. BJOG. 2009 Dec; 116(13):1805-8.
Score: 0,046
-
Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors. J Virol. 2009 Sep; 83(17):8925-37.
Score: 0,045
-
Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance. AIDS. 2009 Apr 27; 23(7):809-16.
Score: 0,045
-
Development of phenotypic HIV-1 drug resistance after exposure to single-dose nevirapine. J Acquir Immune Defic Syndr. 2008 Dec 15; 49(5):538-43.
Score: 0,044
-
Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004. Antivir Ther. 2008; 13 Suppl 2:101-7.
Score: 0,041
-
Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations. Transfusion. 2008 Feb; 48(2):295-303.
Score: 0,040
-
National HIV incidence measures--new insights into the South African epidemic. S Afr Med J. 2007 Mar; 97(3):194-9.
Score: 0,038
-
Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings. Pediatr Infect Dis J. 2005 Nov; 24(11):993-7.
Score: 0,035
-
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005 Nov; 2(11):e298.
Score: 0,035
-
Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa. AIDS Res Hum Retroviruses. 2005 Apr; 21(4):285-91.
Score: 0,034
-
Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. J Immunol. 2004 Oct 01; 173(7):4607-17.
Score: 0,033
-
Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis. 2009 Apr 01; 199(7):958-64.
Score: 0,011
-
Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa. J Acquir Immune Defic Syndr. 2004 May 01; 36(1):613-21.
Score: 0,008